Stem Cells Transl Med 2015 Mar 9;4(3):261-8. Epub 2015 Feb 9.
BAMM Labs, Canary Center at Stanford for Early Cancer Detection, Stanford University School of Medicine, Palo Alto, California, USA; BAMM Labs, Department of Medicine and Center for Infertility and Reproductive Surgery, Obstetrics Gynecology and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA
Hormone replacement therapies have become important for treating diseases such as premature ovarian failure or menopausal complications. The clinical use of bioidentical hormones might significantly reduce some of the potential risks reportedly associated with the use of synthetic hormones. In the present study, we demonstrate the utility and advantage of a microfluidic chip culture system to enhance the development of personalized, on-demand, treatment modules using embryoid bodies (EBs). Read More